Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
about
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesotheliomaTS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.Antimetabolites in the treatment of advanced pleural mesothelioma: a network meta-analysis of randomized clinical trials.
P2860
Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@en
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@nl
type
label
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@en
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@nl
prefLabel
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@en
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@nl
P2093
P1433
P1476
Raltitrexed plus cisplatin is ...... alignant pleural mesothelioma.
@en
P2093
Beth Woods
Nicholas Thatcher
Noman Paracha
P304
P356
10.1016/J.LUNGCAN.2011.07.011
P577
2011-09-19T00:00:00Z